Sphera Funds Management as of June 30, 2020
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 86 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr Put Put Option (XBI) | 7.9 | $84M | 750k | 111.95 | |
| Abbvie (ABBV) | 6.8 | $72M | 735k | 98.18 | |
| Merck & Co (MRK) | 5.7 | $61M | 784k | 77.33 | |
| Spdr S&p 500 Etf Tr Put Put Option (SPY) | 5.5 | $58M | 189k | 308.36 | |
| Sanofi Sponsored Adr (SNY) | 5.4 | $57M | 1.1M | 51.05 | |
| Astrazeneca Sponsored Adr (AZN) | 4.4 | $47M | 890k | 52.89 | |
| Johnson & Johnson (JNJ) | 4.0 | $42M | 300k | 140.63 | |
| Bristol Myers Squibb (BMY) | 3.9 | $41M | 700k | 58.80 | |
| Invesco Qqq Tr Put Put Option (QQQ) | 3.7 | $39M | 158k | 247.60 | |
| Pfizer Put Put Option (PFE) | 3.1 | $33M | 1.0M | 32.70 | |
| Novo-nordisk A S Adr (NVO) | 2.5 | $26M | 400k | 65.48 | |
| Amicus Therapeutics (FOLD) | 2.3 | $25M | 1.6M | 15.08 | |
| Nice Sponsored Adr (NICE) | 2.3 | $25M | 129k | 189.24 | |
| Sarepta Therapeutics (SRPT) | 1.9 | $20M | 123k | 160.34 | |
| Amgen (AMGN) | 1.8 | $19M | 80k | 235.86 | |
| Deciphera Pharmaceuticals (DCPH) | 1.6 | $17M | 283k | 59.72 | |
| Microsoft Corporation (MSFT) | 1.6 | $17M | 82k | 203.50 | |
| Novartis Sponsored Adr (NVS) | 1.5 | $16M | 180k | 87.34 | |
| Eli Lilly & Co. (LLY) | 1.4 | $15M | 90k | 164.18 | |
| Reata Pharmaceuticals Cl A | 1.2 | $13M | 82k | 156.02 | |
| Fiverr Intl Ord Shs (FVRR) | 1.2 | $12M | 167k | 73.82 | |
| Y Mabs Therapeutics (YMAB) | 1.1 | $12M | 282k | 43.20 | |
| Amazon (AMZN) | 1.1 | $12M | 4.3k | 2758.80 | |
| Allot SHS (ALLT) | 0.9 | $10M | 964k | 10.47 | |
| Homology Medicines | 0.9 | $10M | 659k | 15.19 | |
| Myokardia | 0.9 | $9.7M | 100k | 96.62 | |
| Wix SHS (WIX) | 0.9 | $9.6M | 38k | 256.23 | |
| Iovance Biotherapeutics (IOVA) | 0.9 | $9.6M | 348k | 27.45 | |
| Trillium Therapeutics Com New | 0.9 | $9.5M | 1.2M | 8.09 | |
| Kornit Digital SHS (KRNT) | 0.9 | $9.4M | 177k | 53.38 | |
| Passage Bio (PASG) | 0.9 | $9.4M | 344k | 27.33 | |
| Fiserv (FI) | 0.9 | $9.3M | 95k | 97.62 | |
| Kura Oncology (KURA) | 0.8 | $8.7M | 535k | 16.30 | |
| Mirati Therapeutics | 0.8 | $8.2M | 72k | 114.17 | |
| Axovant Gene The | 0.8 | $8.1M | 2.9M | 2.82 | |
| Fate Therapeutics (FATE) | 0.7 | $7.7M | 225k | 34.31 | |
| Repare Therapeutics Ord (RPTX) | 0.7 | $7.6M | 245k | 31.02 | |
| Karyopharm Therapeutics (KPTI) | 0.7 | $7.4M | 393k | 18.94 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.7 | $7.2M | 583k | 12.33 | |
| Rocket Pharmaceuticals (RCKT) | 0.7 | $7.1M | 340k | 20.93 | |
| Concert Pharmaceuticals I equity | 0.7 | $7.0M | 701k | 9.95 | |
| Palo Alto Networks (PANW) | 0.6 | $6.9M | 30k | 229.67 | |
| Solaredge Technologies (SEDG) | 0.6 | $6.4M | 46k | 138.77 | |
| Aprea Therapeutics | 0.6 | $6.1M | 158k | 38.78 | |
| Krystal Biotech (KRYS) | 0.6 | $6.0M | 145k | 41.42 | |
| Intra Cellular Therapies Call Call Option (ITCI) | 0.6 | $5.9M | 229k | 25.67 | |
| Adma Biologics (ADMA) | 0.5 | $5.8M | 2.0M | 2.93 | |
| Dover Corporation (DOV) | 0.5 | $5.6M | 58k | 96.57 | |
| Domino's Pizza (DPZ) | 0.5 | $5.4M | 15k | 369.46 | |
| X4 Pharmaceuticals (XFOR) | 0.5 | $5.3M | 566k | 9.32 | |
| Retrophin | 0.5 | $5.1M | 250k | 20.41 | |
| Larimar Therapeutics (LRMR) | 0.5 | $5.1M | 397k | 12.85 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 0.5 | $5.1M | 34k | 147.91 | |
| Uniqure Nv SHS (QURE) | 0.5 | $5.0M | 110k | 45.06 | |
| Syndax Pharmaceuticals (SNDX) | 0.4 | $4.7M | 320k | 14.82 | |
| Exicure | 0.4 | $4.6M | 1.9M | 2.44 | |
| Zymeworks | 0.4 | $4.2M | 116k | 36.07 | |
| Orgenesis Com New (ORGS) | 0.4 | $4.0M | 666k | 6.08 | |
| Arya Sciences Acquisition Unit 10/04/2023 | 0.4 | $4.0M | 200k | 20.00 | |
| Arya Sciences Acquistion Unit 06/09/2027 | 0.3 | $3.5M | 300k | 11.60 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.3 | $3.4M | 731k | 4.62 | |
| Galera Therapeutics (GRTX) | 0.3 | $3.3M | 469k | 7.14 | |
| 4068594 Enphase Energy (ENPH) | 0.3 | $3.3M | 70k | 47.57 | |
| Wave Life Sciences SHS (WVE) | 0.3 | $3.1M | 293k | 10.41 | |
| Compugen Ord (CGEN) | 0.3 | $3.0M | 200k | 15.02 | |
| Kalvista Pharmaceuticals (KALV) | 0.3 | $2.9M | 240k | 12.10 | |
| Perrigo SHS (PRGO) | 0.3 | $2.8M | 50k | 55.28 | |
| Soleno Therapeutics Com New | 0.3 | $2.7M | 1.2M | 2.22 | |
| Immunovant (IMVT) | 0.2 | $2.6M | 105k | 24.35 | |
| Argenx Se Sponsored Adr (ARGX) | 0.2 | $2.3M | 10k | 225.23 | |
| Akouos | 0.2 | $2.3M | 100k | 22.50 | |
| Akebia Therapeutics (AKBA) | 0.2 | $2.1M | 155k | 13.58 | |
| Corbus Pharmaceuticals Hldgs Call Call Option | 0.2 | $2.0M | 239k | 8.39 | |
| Leap Therapeutics | 0.2 | $1.8M | 880k | 2.09 | |
| Mei Pharma Com New | 0.2 | $1.7M | 410k | 4.13 | |
| Viking Therapeutics (VKTX) | 0.1 | $1.5M | 205k | 7.21 | |
| Neubase Therapeutics Ord | 0.1 | $1.3M | 150k | 8.78 | |
| Immunic (IMUX) | 0.1 | $1.2M | 100k | 12.12 | |
| Iveric Bio | 0.1 | $1.0M | 200k | 5.10 | |
| Bellus Health Com New | 0.1 | $1.0M | 98k | 10.29 | |
| Neos Therapeutics | 0.1 | $651k | 950k | 0.69 | |
| Nice Sys Note 1.250% 1/1 | 0.1 | $573k | 250k | 2.29 | |
| Camtek Ord (CAMT) | 0.0 | $468k | 37k | 12.59 | |
| Tcr2 Therapeutics Inc cs | 0.0 | $461k | 30k | 15.37 | |
| Cellectar Biosciences Com Par | 0.0 | $112k | 88k | 1.28 | |
| Outlook Therapeutics *w Exp 02/18/202 | 0.0 | $33k | 130k | 0.25 |
